iBio (IBIO) News Today → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free IBIO Stock Alerts $2.00 +0.19 (+10.47%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC Filings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 10, 2024 | americanbankingnews.comiBio (NYSEMKT:IBIO) Trading Down 3.2%March 28, 2024 | msn.comiBio, Mesoblast, Kodiak Sciences among healthcare moversMarch 27, 2024 | msn.comMicro-Cap Stock iBio Doubles On Wednesday - Here's WhyMarch 27, 2024 | proactiveinvestors.comiBio partners with AstralBio to develop obesity treatments using AI-driven platformMarch 27, 2024 | marketwatch.comiBio Shares Double After Collaboration Agreement With AstralBioMarch 27, 2024 | investorplace.comWhy Is iBio (IBIO) Stock Up 125% Today?March 27, 2024 | msn.comMega Millions winning numbers for enormous $1.1 billion jackpot on March 26March 27, 2024 | msn.comRon DeSantis signs bill banning social media for kids under 14 in FloridaMarch 27, 2024 | globenewswire.comiBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic DiseasesMarch 26, 2024 | globenewswire.comiBio Announces $15.0 Million Private PlacementFebruary 26, 2024 | marketwatch.comiBio Sells Preclinical PD-1 Antagonist Antibody Program to OtsukaFebruary 26, 2024 | globenewswire.comiBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to OtsukaFebruary 22, 2024 | money.usnews.comiBio IncFebruary 13, 2024 | msn.comHow to capture screenshots on your Mac: A step-by-step guideFebruary 12, 2024 | msn.comTrain hits, kills person who trespassed on tracks in HaywardFebruary 12, 2024 | msn.comUsher's Wife Responds To Alicia Keys Super Bowl DramaJanuary 16, 2024 | finance.yahoo.comiBio Announces Participation in 23rd Annual PepTalk ConferenceDecember 26, 2023 | finance.yahoo.comiBio Amends and Extends Maturity of Credit AgreementDecember 8, 2023 | benzinga.comLooking Into iBio's Recent Short InterestDecember 5, 2023 | marketwatch.comIBio Shares Drop 43% After Public OfferingDecember 5, 2023 | msn.comiBio prices 2.25M shares at $2.00 in public offeringDecember 5, 2023 | markets.businessinsider.comIBio Prices Public Offering Of 2.25 Mln Shares At $2/shrDecember 5, 2023 | finance.yahoo.comiBio, Inc. Announces Pricing of $4.5 Million Public OfferingNovember 28, 2023 | benzinga.comiBio Stock (AMEX:IBIO) Dividends: History, Yield and DatesNovember 28, 2023 | finanznachrichten.deiBio, Inc.: iBio Announces Reverse Stock SplitNovember 28, 2023 | msn.comWhy iBio Stock Is Plunging SharplyNovember 27, 2023 | marketwatch.comStocks to Watch: iBio, AcelyrinNovember 27, 2023 | marketwatch.comIBio Shares Sink 6.2% on 20-to-1 Reverse Stock SplitNovember 27, 2023 | msn.comiBio to undertake reverse stock split at 20-to-1 ratioNovember 27, 2023 | finance.yahoo.comiBio Announces Reverse Stock SplitNovember 16, 2023 | finance.yahoo.comVirus-Like Particle Vaccine Market Latest Report 2023-2031 | InsightAce AnalyticNovember 1, 2023 | finance.yahoo.comiBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with Conditionally Activated MUC16xCD3 BispecificNovember 1, 2023 | finance.yahoo.comiBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with Conditionally Activated MUC16xCD3 BispecificNovember 1, 2023 | finance.yahoo.comPlant-based Vaccines Market Size to Hit 12.9% CAGR, Globally, by 2028 - Exclusive Report by The Insight PartnersOctober 27, 2023 | msn.comiBio files for mixed shelf of undisclosed sizeOctober 22, 2023 | msn.com2 new upscale restaurants bet big on San FranciscoOctober 10, 2023 | finance.yahoo.comiBio to Highlight Technology for Advancing Discovery of Bispecifics at Festival of BiologicsOctober 2, 2023 | finance.yahoo.comiBio Explains Recent Filing of Registration StatementSeptember 27, 2023 | finance.yahoo.comiBio Announces Filing of 2023 Annual Report on SEC Form 10-KSeptember 22, 2023 | finanznachrichten.deiBio, Inc.: iBio Announces Amendment to Credit Agreement with WoodforestSeptember 21, 2023 | finance.yahoo.comiBio Announces Amendment to Credit Agreement with WoodforestAugust 15, 2023 | marketwatch.comiBio Inc. stock falls Tuesday, underperforms marketAugust 14, 2023 | marketwatch.comiBio Inc. stock rises Monday, outperforms marketAugust 14, 2023 | finance.yahoo.comiBio Reports Triple Milestone: In Vivo Proof-of-Concept for Three Programs, a Transformative Step in Advancing its Immuno-Oncology Pre-Clinical Pipeline Towards Clinical DevelopmentAugust 1, 2023 | investing.comPharos IBio Co Ltd (388870)July 5, 2023 | marketwatch.comiBio Inc. stock rises Wednesday, outperforms marketJune 27, 2023 | finance.yahoo.comPlant-based Expression Systems Market - Vaccines and Monoclonal Antibodies accounted for the Largest Market Share | Latest InsightAce StudyJune 27, 2023 | finance.yahoo.comiBio Appoints Dr. Martin Brenner as CEO, Felipe Duran as CFO to Oversee Company’s Next Stage of GrowthJune 16, 2023 | marketwatch.comiBio Inc. stock rises Thursday, outperforms marketJune 13, 2023 | marketwatch.comiBio Shares Rise 14% After Research Deal With National Institute of Allergy and Infectious Diseases Get iBio News Delivered to You Automatically Sign up to receive the latest news and ratings for IBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. IBIO Media Mentions By Week IBIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IBIO News Sentiment▼0.000.54▲Average Medical News Sentiment IBIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IBIO Articles This Week▼01▲IBIO Articles Average Week Get iBio News Delivered to You Automatically Sign up to receive the latest news and ratings for IBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BRTX News Today EIGR News Today PHXM News Today PHGE News Today PCSA News Today SONX News Today AVGR News Today VAPO News Today ENVB News Today TTNP News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEMKT:IBIO) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldA ‘DeFi Summer’ Projected!Crypto 101 MediaHow Biden has already won 2024Porter & CompanyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
